Life Sciences Front
FDA approves semaglutide label expansion
Regulatory decision approves a semaglutide label expansion while distinguishing approval from scientific consensus.
DRUG_APPROVALVERIFIEDSTRONG
LifeWey
Life Sciences
Discovery
Search
Most recent LifeWey events
Latest
DRUG_APPROVALVERIFIEDSTRONGREGULATORY DOCUMENTAPPROVED
FDA approves semaglutide label expansion
Regulatory decision approves a semaglutide label expansion while distinguishing approval from scientific consensus.
Source: FDA2026-08-13
CLINICAL_TRIAL_PHASE_CHANGEDEVELOPINGMODERATEREGULATORY DOCUMENT
ClinicalTrials.gov updates semaglutide obesity trial phase
Registry update notes a phase change for a semaglutide obesity study and keeps uncertainty visible.
Source: ClinicalTrials.gov2026-08-13
RESEARCH_PUBLICATIONDEVELOPINGMODERATEPEER REVIEWED
NEJM publishes semaglutide obesity study
Peer-reviewed publication reports a semaglutide obesity result with clear uncertainty limits.
Semaglutide · DRUGObesity · DISEASENew England Journal of Medicine · JOURNALSemaglutide evidence dossier · STUDY
Source: PubMed2026-08-13
Evidence-first
Research
RESEARCH_PUBLICATIONDEVELOPINGMODERATEPEER REVIEWED
NEJM publishes semaglutide obesity study
Peer-reviewed publication reports a semaglutide obesity result with clear uncertainty limits.
Semaglutide · DRUGObesity · DISEASENew England Journal of Medicine · JOURNALSemaglutide evidence dossier · STUDY
Source: PubMed2026-08-13
Registry and stage
Clinical Trials
CLINICAL_TRIAL_PHASE_CHANGEDEVELOPINGMODERATEREGULATORY DOCUMENT
ClinicalTrials.gov updates semaglutide obesity trial phase
Registry update notes a phase change for a semaglutide obesity study and keeps uncertainty visible.
Source: ClinicalTrials.gov2026-08-13
Drug and company updates
Pharma
DRUG_APPROVALVERIFIEDSTRONGREGULATORY DOCUMENTAPPROVED
FDA approves semaglutide label expansion
Regulatory decision approves a semaglutide label expansion while distinguishing approval from scientific consensus.
Source: FDA2026-08-13
Authorities and decisions
Regulatory
DRUG_APPROVALVERIFIEDSTRONGREGULATORY DOCUMENTAPPROVED
FDA approves semaglutide label expansion
Regulatory decision approves a semaglutide label expansion while distinguishing approval from scientific consensus.
Source: FDA2026-08-13
Representative science entities
Entities
CLINICAL_TRIALPublic
NCT12345678
Clinical trial · Stage: PHASE 3
DRUGPublic
Semaglutide
Drug · Tracked through publications, trial updates, and regulatory events.
COMPANYPublic
Novo Nordisk
Company · Programs and regulatory context tracked through related events.
REGULATORPublic
FDA
Regulatory authority · Tracks approvals, label changes, and decisions.